Biotechnology Assets, S.A. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.396305 million compared to EUR 0.202997 million a year ago. Net loss was EUR 1.94 million compared to EUR 3.01 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.332 EUR | -0.60% | -1.19% | -16.16% |
04-05 | Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Biotechnology Assets, S.A. Auditor Raises 'Going Concern' Doubt | CI |
1st Jan change | Capi. | |
---|---|---|
-16.16% | 20.72M | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- BST Stock
- News Biotechnology Assets, S.A.
- Biotechnology Assets, S.A. Reports Earnings Results for the Full Year Ended December 31, 2022